Fourth quarter Molecular Volume increased 21% year-over-year compared to Q4 2023, and 17% for the Full Year resulting in double-digit Q4 and YTD revenue growth. “The Company achieved record test volume, test revenue, income, and cash collections in Q4 and full year 2024,” said Chris McCarthy, CFO. “The Company’s strategic focus on operational and efficiency improvements also delivered record gross and net income margins.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio